The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth

被引:34
作者
Schieffer, B
Bernstein, KE
Marrero, MB
机构
[1] EMORY UNIV,DEPT PATHOL,ATLANTA,GA 30322
[2] EMORY UNIV,CTR MOLEC & CELLULAR SIGNALING,ATLANTA,GA 30322
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1996年 / 74卷 / 02期
关键词
angiotensin II; angiotensin II type 1 receptor; tyrosine phosphorylation; Janus kinase signal transducers and activators of transcription pathway; phospholipase C; src kinase;
D O I
10.1007/BF00196783
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Most cell types, including vascular smooth muscle cells and rat kidney mesangial cells, are controlled mainly by two types of cell surface receptors: (a) single membrane-spanning tyrosine kinase receptors for growth factors and (b) seven-transmembrane G-protein linked receptors for vasoactive peptides such as angiotensin II, vasopressin, and endothelin. These vasoactive peptide hormones also act as growth factors in normal and abnormal cell development. However, in contrast to the growth factor receptors (e.g., epidermal growth factor receptor and platelet-derived growth factor receptor), the G-protein linked receptors, such as the angiotensin II AT(1) receptor, lack cytoplasmic tyrosine kinase domains. Nevertheless, angiotensin II has recently been demonstrated to cause increased tyrosine phosphorylation of numerous proteins in several cellular systems. For example, angiotensin II has been reported to induce the tyrosine phosphorylation of the gamma-isoform of phospholipase C, pp120, pp125(FAK), and members of the janus kinase/signal transducer and activator of transcription pathway. Furthermore, angiotensin II seems to modulate the activity of the soluble cytoplasmic tyrosine kinase pp60(c-src), and this tyrosine kinase has been implicated in the phosphorylation of some of the above proteins. Understanding the biochemistry of tyrosine phosphorylation involved in G-protein coupled receptors, such as the AT(1) receptor, may therefore lead to the development of new pharmacological interventions important in cardiovascular diseases.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 57 条
[1]  
AKIYAMA T, 1991, METHOD ENZYMOL, V201, P362
[2]   ANGIOTENSIN INCREASES INOSITOL TRISPHOSPHATE AND CALCIUM IN VASCULAR SMOOTH-MUSCLE [J].
ALEXANDER, RW ;
BROCK, TA ;
GIMBRONE, MA ;
RITTENHOUSE, SE .
HYPERTENSION, 1985, 7 (03) :447-451
[3]   ANGIOTENSIN-II-INDUCED VASCULAR SMOOTH-MUSCLE CELL HYPERTROPHY - PDGF A-CHAIN MEDIATES THE INCREASE IN CELL-SIZE [J].
BERK, BC ;
RAO, GN .
JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 154 (02) :368-380
[4]  
BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P59
[5]   ACTIVATION OF THE STAT PATHWAY BY ANGIOTENSIN-II IN T3CHO/AT(1A) CELLS - CROSS-TALK BETWEEN ANGIOTENSIN-II AND INTERLEUKIN-6 NUCLEAR SIGNALING [J].
BHAT, GJ ;
THEKKUMKARA, TJ ;
THOMAS, WG ;
CONRAD, KM ;
BAKER, KM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19059-19065
[6]  
BHAT GJ, 1994, J BIOL CHEM, V269, P3443
[7]  
CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463
[8]  
COCKCROFT S, 1992, BIOCHEM J, V288, P1
[9]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[10]  
DHAR A, 1994, J BIOL CHEM, V269, P9123